Cancer/ Healthcare/ News/ UK & Europe Sandoz weighs into European rituximab biosimilar market Andrew McConaghie biosimilars, Europe, MabThera, Sandoz 0 Comment Sandoz has gained European approval for its biosimilar version of Roche’s blockbuster MabThera/Rituxan (rituximab) to be called Rixathon. The Share X Sandoz weighs into European rituximab biosimilar market https://pharmaphorum.com/news/sandoz-weighs-european-rituximab-biosimilar-market/
